Articles

Page 145 of 147

Debate: PCI or CABG for multivessel disease? Viewpoint: No clear winner in an unfair fight

The Arterial Revascularization Therapy Study (ARTS) and the Stent or Surgery (SoS) trial each randomized patients with multivessel disease to either stenting or bypass surgery. The ARTS showed no difference in...

Authors: Deepak L Bhatt and Eric J Topol

Citation: Trials 2001 2:260

Content type: Commentary

Published on: 25 October 2001
- View Full Text
- View PDF
Therapeutic angiogenesis for cardiovascular disease

The identification of angiogenic growth factors, such as vascular endothelial growth factor and fibroblast growth factor, has fueled interest in using such factors to induce therapeutic angiogenesis. The resul...

Authors: Yin-Shan Ng and Patricia A D'Amore

Citation: Trials 2001 2:278

Content type: Review

Published on: 24 October 2001
- View Full Text
- View PDF
Diabetic AMI patients receive suboptimal thrombolytic treatment

Authors: Joanna Lyford

Citation: Current Controlled Trials in Cardiovascular Medicine 2001 2:72161

Content type: Paper Report

Published on: 19 October 2001
- View Full Text
- View PDF
Tamoxifen is not associated with increased CV event rate

Authors: Joanna Lyford

Citation: Current Controlled Trials in Cardiovascular Medicine 2001 2:72160

Content type: Paper Report

Published on: 19 October 2001
- View Full Text
- View PDF
Antioxidant effect of estrogen may protect heart cells from inflammation

Authors: Joanna Lyford

Citation: Current Controlled Trials in Cardiovascular Medicine 2001 2:72158

Content type: Paper Report

Published on: 19 October 2001
- View Full Text
- View PDF
Long-term weight loss lowers BP in mildly hypertensive overweight patients

Authors: Joanna Lyford

Citation: Current Controlled Trials in Cardiovascular Medicine 2001 2:72157

Content type: Paper Report

Published on: 19 October 2001
- View Full Text
- View PDF
Patients with AMI continue to delay hospital presentation

Authors: Joanna Lyford

Citation: Current Controlled Trials in Cardiovascular Medicine 2001 2:72155

Content type: Paper Report

Published on: 19 October 2001
- View Full Text
- View PDF
'No independent link' between diabetes and poor outcomes after CABG/PTCA

Authors: Joanna Lyford

Citation: Current Controlled Trials in Cardiovascular Medicine 2001 2:72154

Content type: Paper Report

Published on: 19 October 2001
- View Full Text
- View PDF
Statins reduce dementia risk by 70%

Authors: Joanna Lyford

Citation: Current Controlled Trials in Cardiovascular Medicine 2001 2:72150

Content type: Paper Report

Published on: 19 October 2001
- View Full Text
- View PDF
Caerphilly study finds no link between homocysteine and CHD

Authors: Joanna Lyford

Citation: Current Controlled Trials in Cardiovascular Medicine 2001 2:72106

Content type: Paper Report

Published on: 18 October 2001
- View Full Text
- View PDF
Prognostic value of ultrasonographic measurements in stable angina

Authors: Joanna Lyford

Citation: Current Controlled Trials in Cardiovascular Medicine 2001 2:72105

Content type: Paper Report

Published on: 18 October 2001
- View Full Text
- View PDF
Risk of intraparenchymal stroke increased by low saturated fat intake in women

Authors: Joanna Lyford

Citation: Current Controlled Trials in Cardiovascular Medicine 2001 2:72104

Content type: Paper Report

Published on: 18 October 2001
- View Full Text
- View PDF
Diastolic dysfunction as predominant form of CHF confirmed

Authors: Joanna Lyford

Citation: Current Controlled Trials in Cardiovascular Medicine 2001 2:72103

Content type: Paper Report

Published on: 18 October 2001
- View Full Text
- View PDF
Noninvasive tests for CAD unsuitable in renal failure patients

Authors: Joanna Lyford

Citation: Current Controlled Trials in Cardiovascular Medicine 2001 2:72102

Content type: Paper Report

Published on: 18 October 2001
- View Full Text
- View PDF
Diabetes and insulin use on AMI survival - is enough being done?

Authors: Joanna Lyford

Citation: Current Controlled Trials in Cardiovascular Medicine 2001 2:72101

Content type: Paper Report

Published on: 18 October 2001
- View Full Text
- View PDF
Coronary event risk needs to be quantified before advising aspirin for primary prevention

Authors: Joanna Lyford

Citation: Current Controlled Trials in Cardiovascular Medicine 2001 2:72100

Content type: Paper Report

Published on: 18 October 2001
- View Full Text
- View PDF
Sudden vigorous exercise associated with increased risk of death

Authors: Joanna Lyford

Citation: Current Controlled Trials in Cardiovascular Medicine 2001 2:72062

Content type: Paper Report

Published on: 18 October 2001
- View Full Text
- View PDF
Evidence for increased risk of venous thrombosis during air travel

Authors: Joanna Lyford

Citation: Current Controlled Trials in Cardiovascular Medicine 2001 2:72061

Content type: Paper Report

Published on: 18 October 2001
- View Full Text
- View PDF
Different mechanisms by which CMV predisposes to CAD in men and women

Authors: Joanna Lyford

Citation: Current Controlled Trials in Cardiovascular Medicine 2001 2:72060

Content type: Paper Report

Published on: 18 October 2001
- View Full Text
- View PDF
Plaque morphology directly related to platelet activation in ACS

Authors: Joanna Lyford

Citation: Current Controlled Trials in Cardiovascular Medicine 2001 2:72059

Content type: Paper Report

Published on: 18 October 2001
- View Full Text
- View PDF
Multi-drug risk reduction strategy safe in peripheral artery disease

Authors: Joanna Lyford

Citation: Current Controlled Trials in Cardiovascular Medicine 2001 2:72058

Content type: Paper Report

Published on: 18 October 2001
- View Full Text
- View PDF
Preinfarction angina protects against in-hospital adverse outcomes in the elderly

Authors: Joanna Lyford

Citation: Current Controlled Trials in Cardiovascular Medicine 2001 2:72057

Content type: Paper Report

Published on: 18 October 2001
- View Full Text
- View PDF
Community-based study highlights sex differential in post-MI mortality

Authors: Joanna Lyford

Citation: Current Controlled Trials in Cardiovascular Medicine 2001 2:72056

Content type: Paper Report

Published on: 18 October 2001
- View Full Text
- View PDF
More evidence for inflammatory markers in predicting CHD risk

Authors: Joanna Lyford

Citation: Current Controlled Trials in Cardiovascular Medicine 2001 2:72055

Content type: Paper Report

Published on: 18 October 2001
- View Full Text
- View PDF
Epifibatide is justified in community hospital treatment of ACS

Authors: Joanna Lyford

Citation: Current Controlled Trials in Cardiovascular Medicine 2001 2:72054

Content type: Paper Report

Published on: 18 October 2001
- View Full Text
- View PDF
Statins not effective in reducing osteoporotic fractures

Authors: Joanna Lyford

Citation: Current Controlled Trials in Cardiovascular Medicine 2001 2:72053

Content type: Paper Report

Published on: 18 October 2001
- View Full Text
- View PDF
Lack of effect of HRT on stroke/TIA risk 'not surprising'

Authors: Joanna Lyford

Citation: Current Controlled Trials in Cardiovascular Medicine 2001 2:72052

Content type: Paper Report

Published on: 18 October 2001
- View Full Text
- View PDF
Tamoxifen may reduce CHD risk via inflammatory mediators

Authors: Joanna Lyford

Citation: Current Controlled Trials in Cardiovascular Medicine 2001 2:72051

Content type: Paper Report

Published on: 18 October 2001
- View Full Text
- View PDF
Major study finds no link between gum disease and CV risk

Authors: Joanna Lyford

Citation: Current Controlled Trials in Cardiovascular Medicine 2001 2:72050

Content type: Paper Report

Published on: 18 October 2001
- View Full Text
- View PDF
How well can blood pressure be controlled? Progress report on the Systolic Hypertension in Europe Follow-Up Study (Syst-Eur 2)

The randomised, double-blind, placebo-controlled Systolic Hypertension in Europe trial (Syst-Eur 1) proved that blood pressure (BP) lowering therapy starting with nitrendipine reduces the risk of cardiovascula...

Authors: Lutgarde Thijs, Jan A Staessen, Sonia Beleva, Willem H Birkenhäger, Christopher J Bulpitt, Hilde Celis, Astrid E Fletcher, Rumjana Kermova, Gastone Leonetti, Tovio Laks, Stefan Mantov, Choudomir Nachev, Cinzia Sarti, Jaakko Tuomilehto and Robert H Fagard

Citation: Trials 2001 2:298

Content type: Research

Published on: 18 October 2001
- View Full Text
- View PDF
Metoprolol vs carvedilol in heart failure

Authors: Michael Norton

Citation: Current Controlled Trials in Cardiovascular Medicine 2001 2:72005

Content type: Paper Report

Published on: 17 October 2001
- View Full Text
- View PDF
Intravenous dofetilide vs amiodarone

Authors: Niall Mulvahill

Citation: Current Controlled Trials in Cardiovascular Medicine 2001 2:72003

Content type: Paper Report

Published on: 17 October 2001
- View Full Text
- View PDF
Amiodarone as a first choice drug

Authors: Niall Mulvahill

Citation: Current Controlled Trials in Cardiovascular Medicine 2001 2:72002

Content type: Paper Report

Published on: 17 October 2001
- View Full Text
- View PDF
Effects of alcohol consumption in patients with left ventricular dysfunction

Authors: T Irvine

Citation: Current Controlled Trials in Cardiovascular Medicine 2001 2:72001

Content type: Paper Report

Published on: 17 October 2001
- View Full Text
- View PDF
Dietary changes take two years to reduce heart attack risk

Authors: Joanna Lyford

Citation: Current Controlled Trials in Cardiovascular Medicine 2001 2:71954

Content type: Paper Report

Published on: 17 October 2001
- View Full Text
- View PDF
Orbofiban in unstable angina (OPUS-TIMI 16 trial)

Authors: Gethin Ellis

Citation: Current Controlled Trials in Cardiovascular Medicine 2001 2:71901

Content type: Paper Report

Published on: 17 October 2001
- View Full Text
- View PDF
Intracoronary radiation for in-stent restenosis

Authors: Mehrdad Malenkianpoor

Citation: Current Controlled Trials in Cardiovascular Medicine 2001 2:71900

Content type: Paper Report

Published on: 17 October 2001
- View Full Text
- View PDF
Cytokines as new treatment targets in chronic heart failure

Inflammatory cytokines may negatively influence contractility and contribute to the remodelling process in the failing myocardium. Traditional cardiovascular drugs appear to have little influence on the overal...

Authors: Jan Kristian Damås, Lars Gullestad and Pål Aukrust

Citation: Trials 2001 2:271

Content type: Review

Published on: 16 October 2001
- View Full Text
- View PDF
Withdrawal of cerivastatin from the world market

Cerivastatin was recently withdrawn from the market because of 52 deaths attributed to drug-related rhabdomyolysis that lead to kidney failure. The risk was found to be higher among patients who received the f...

Authors: Curt D Furberg and Bertram Pitt

Citation: Trials 2001 2:205

Content type: Commentary

Published on: 26 September 2001
- View Full Text
- View PDF
Diuretics: again the first step in the treatment of most patients with hypertension

The results and interpretations of the most recent controlled clinical trials on antihypertensive drugs have fuelled the debate about the drug that should be used to begin treatment for hypertension. Every com...

Authors: Flávio Danni Fuchs

Citation: Trials 2001 2:244

Content type: Review

Published on: 25 September 2001
- View Full Text
- View PDF
Anti-atherogenic effects of fibrates in type 2 diabetes

Type 2 diabetes is an increasing cause of premature coronary heart disease. Several trials with lipid-modifying therapy have included sufficient numbers of diabetics to indicate that treatment of diabetic dysl...

Authors: Philip Barter

Citation: Trials 2001 2:218

Content type: Commentary

Published on: 24 September 2001
- View Full Text
- View PDF
Hypothesis to explain poor outcomes in the ALLHAT and V-HeFT trials: decreased expression of heat shock proteins

An explanation for the higher incidence of cardiovascular disease and heart failure in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) with doxazosin and the Vasodilato...

Authors: Philip L Hooper

Citation: Trials 2001 2:251

Content type: Commentary

Published on: 20 September 2001
- View Full Text
- View PDF
ELITE II and Val-HeFT are different trials: together what do they tell us?

The Losartan Heart Failure Survival Study (ELITE II) and the Valsartan Heart Failure Trial (Val-HeFT) both evaluated the efficacy and tolerability of a selective angiotensin II receptor antagonist on morbidity...

Authors: Kenneth Dickstein

Citation: Trials 2001 2:240

Content type: Review

Published on: 19 September 2001
- View Full Text
- View PDF
Should all patients receive dual chamber pacing ICDs? The rationale for the DAVID trial

All of the prospective multicenter trials that support the use of implantable defibrillators have used single chamber pacemakers/implantable cardiovertor defibrillators (ICDs). Despite the significantly increa...

Authors: Bruce L Wilkoff

Citation: Trials 2001 2:215

Content type: Commentary

Published on: 18 September 2001
- View Full Text
- View PDF
Arterial indications for the low molecular weight heparins

Antithrombotic treatment is of proven importance in patients with acute coronary syndromes. There is now accumulating evidence from several clinical trials in patients with unstable angina pectoris that the lo...

Authors: Walter Ageno and Menno V Huisman

Citation: Trials 2001 2:233

Content type: Review

Published on: 11 September 2001
- View Full Text
- View PDF
Cardiac rehabilitation: a comprehensive review

Cardiac rehabilitation (CR) is a commonly used treatment for men and women with cardiovascular disease. To date, no single study has conclusively demonstrated a comprehensive benefit of CR. Numerous individual...

Authors: Scott A Lear and Andrew Ignaszewski

Citation: Trials 2001 2:221

Content type: Review

Published on: 10 September 2001
- View Full Text
- View PDF
Do we need clinical trials to test the ability of transdermal HRT to prevent coronary heart disease?

Postmenopausal hormone replacement therapy (HRT) with oral oestrogen was predicted to reduce coronary heart disease (CHD) risk by 50%. Randomized controlled trials show no such benefit, however, pointing inste...

Authors: David Crook

Citation: Trials 2001 2:211

Content type: Commentary

Published on: 10 September 2001
- View Full Text
- View PDF
Cellular cardiomyoplasty with autologous skeletal myoblasts for ischemic heart disease and heart failure

Cell transplantation to repair or regenerate injured myocardium is a new frontier in the treatment of cardiovascular disease. Even though it is based on many years of pre-clinical studies, much remains to be u...

Authors: Doris A Taylor

Citation: Trials 2001 2:208

Content type: Commentary

Published on: 10 September 2001
- View Full Text
- View PDF
Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease

Glycoprotein IIb/IIIa inhibitors represent a new promising class of antiplatelet medications. Their use in acute coronary syndromes and for patients undergoing percutaneous coronary intervention has been the s...

Authors: Jassim Al Suwaidi and Amar M Salam

Citation: Trials 2001 2:171

Content type: Review

Published on: 26 July 2001
- View Full Text
- View PDF
Design and intermediate results of the Lower Extremity Arterial Disease Event Reduction (LEADER)* trial of bezafibrate in men with lower extremity arterial disease [ISRCTN41194621]

Raised levels of both triglycerides and fibrinogen, each of which are reduced by bezafibrate, may contribute to lower extremity arterial disease (LEAD). This condition is characterized by a particularly high i...

Authors: Thomas W Meade

Citation: Trials 2001 2:195

Content type: Research

Published on: 23 July 2001
- View Full Text
- View PDF

Articles

Follow

Annual Journal Metrics

Trials

Contact us